123 related articles for article (PubMed ID: 12763686)
1. Innate and adaptive mucosal immunity in protection against HIV infection.
Lehner T
Vaccine; 2003 Jun; 21 Suppl 2():S68-76. PubMed ID: 12763686
[TBL] [Abstract][Full Text] [Related]
2. Innate and adaptive mucosal immunity in protection against HIV infection.
Bergmeier LA; Lehner T
Adv Dent Res; 2006 Apr; 19(1):21-8. PubMed ID: 16672545
[TBL] [Abstract][Full Text] [Related]
3. A rational basis for mucosal vaccination against HIV infection.
Lehner T; Bergmeier L; Wang Y; Tao L; Mitchell E
Immunol Rev; 1999 Aug; 170():183-96. PubMed ID: 10566151
[TBL] [Abstract][Full Text] [Related]
4. Mucosal immunity and protection against HIV/SIV infection: strategies and challenges for vaccine design.
Demberg T; Robert-Guroff M
Int Rev Immunol; 2009; 28(1):20-48. PubMed ID: 19241252
[TBL] [Abstract][Full Text] [Related]
5. Vaccination with the Conserved Caveolin-1 Binding Motif in Human Immunodeficiency Virus Type 1 Glycoprotein gp41 Delays the Onset of Viral Infection and Provides Partial Protection in Simian/Human Immunodeficiency Virus-Challenged Cynomolgus Macaques.
Hovanessian AG; Soundaramourty C; Benferhat R; Le Grand R; Dereuddre-Bosquet N; Krust B; Estaquier J
J Virol; 2018 Sep; 92(18):. PubMed ID: 29976675
[TBL] [Abstract][Full Text] [Related]
6. Rapid virus dissemination in infant macaques after oral simian immunodeficiency virus exposure in the presence of local innate immune responses.
Abel K; Pahar B; Van Rompay KK; Fritts L; Sin C; Schmidt K; Colón R; McChesney M; Marthas ML
J Virol; 2006 Jul; 80(13):6357-67. PubMed ID: 16775324
[TBL] [Abstract][Full Text] [Related]
7. Qualitative T-helper responses to multiple viral antigens correlate with vaccine-induced immunity to simian/human immunodeficiency virus infection.
Mooij P; Nieuwenhuis IG; Knoop CJ; Doms RW; Bogers WM; Ten Haaft PJ; Niphuis H; Koornstra W; Bieler K; Köstler J; Morein B; Cafaro A; Ensoli B; Wagner R; Heeney JL
J Virol; 2004 Apr; 78(7):3333-42. PubMed ID: 15016855
[TBL] [Abstract][Full Text] [Related]
8. Protection against chronic infection and AIDS by an HIV envelope peptide-cocktail vaccine in a pathogenic SHIV-rhesus model.
Nehete PN; Chitta S; Hossain MM; Hill L; Bernacky BJ; Baze W; Arlinghaus RB; Sastry KJ
Vaccine; 2001 Dec; 20(5-6):813-25. PubMed ID: 11738745
[TBL] [Abstract][Full Text] [Related]
9. Mucosal immunity and HIV-1 infection: applications for mucosal AIDS vaccine development.
Belyakov IM; Ahlers JD
Curr Top Microbiol Immunol; 2012; 354():157-79. PubMed ID: 21203884
[TBL] [Abstract][Full Text] [Related]
10. A novel functional CTL avidity/activity compartmentalization to the site of mucosal immunization contributes to protection of macaques against simian/human immunodeficiency viral depletion of mucosal CD4+ T cells.
Belyakov IM; Isakov D; Zhu Q; Dzutsev A; Berzofsky JA
J Immunol; 2007 Jun; 178(11):7211-21. PubMed ID: 17513770
[TBL] [Abstract][Full Text] [Related]
11. A novel HIV-CCR5 receptor vaccine strategy in the control of mucosal SIV/HIV infection.
Bogers WM; Bergmeier LA; Ma J; Oostermeijer H; Wang Y; Kelly CG; Ten Haaft P; Singh M; Heeney JL; Lehner T
AIDS; 2004 Jan; 18(1):25-36. PubMed ID: 15090826
[TBL] [Abstract][Full Text] [Related]
12. Mucosally-administered human-simian immunodeficiency virus DNA and fowlpoxvirus-based recombinant vaccines reduce acute phase viral replication in macaques following vaginal challenge with CCR5-tropic SHIVSF162P3.
Kent SJ; Dale CJ; Ranasinghe C; Stratov I; De Rose R; Chea S; Montefiori DC; Thomson S; Ramshaw IA; Coupar BE; Boyle DB; Law M; Wilson KM; Ramsay AJ
Vaccine; 2005 Oct; 23(42):5009-21. PubMed ID: 15985317
[TBL] [Abstract][Full Text] [Related]
13. Multispecific vaccine-induced mucosal cytotoxic T lymphocytes reduce acute-phase viral replication but fail in long-term control of simian immunodeficiency virus SIVmac239.
Vogel TU; Reynolds MR; Fuller DH; Vielhuber K; Shipley T; Fuller JT; Kunstman KJ; Sutter G; Marthas ML; Erfle V; Wolinsky SM; Wang C; Allison DB; Rud EW; Wilson N; Montefiori D; Altman JD; Watkins DI
J Virol; 2003 Dec; 77(24):13348-60. PubMed ID: 14645590
[TBL] [Abstract][Full Text] [Related]
14. Analysis of Complement-Mediated Lysis of Simian Immunodeficiency Virus (SIV) and SIV-Infected Cells Reveals Sex Differences in Vaccine-Induced Immune Responses in Rhesus Macaques.
Miller-Novak LK; Das J; Musich TA; Demberg T; Weiner JA; Venzon DJ; Mohanram V; Vargas-Inchaustegui DA; Tuero I; Ackerman ME; Alter G; Robert-Guroff M
J Virol; 2018 Oct; 92(19):. PubMed ID: 30021899
[TBL] [Abstract][Full Text] [Related]
15. Heterologous envelope immunogens contribute to AIDS vaccine protection in rhesus monkeys.
Letvin NL; Huang Y; Chakrabarti BK; Xu L; Seaman MS; Beaudry K; Korioth-Schmitz B; Yu F; Rohne D; Martin KL; Miura A; Kong WP; Yang ZY; Gelman RS; Golubeva OG; Montefiori DC; Mascola JR; Nabel GJ
J Virol; 2004 Jul; 78(14):7490-7. PubMed ID: 15220422
[TBL] [Abstract][Full Text] [Related]
16. Induction of HIV-specific antibody response and protection against vaginal SHIV transmission by intranasal immunization with inactivated SHIV-capturing nanospheres in macaques.
Miyake A; Akagi T; Enose Y; Ueno M; Kawamura M; Horiuchi R; Hiraishi K; Adachi M; Serizawa T; Narayan O; Akashi M; Baba M; Hayami M
J Med Virol; 2004 Jul; 73(3):368-77. PubMed ID: 15170630
[TBL] [Abstract][Full Text] [Related]
17. Adjuvanting a Simian Immunodeficiency Virus Vaccine with Toll-Like Receptor Ligands Encapsulated in Nanoparticles Induces Persistent Antibody Responses and Enhanced Protection in TRIM5α Restrictive Macaques.
Kasturi SP; Kozlowski PA; Nakaya HI; Burger MC; Russo P; Pham M; Kovalenkov Y; Silveira ELV; Havenar-Daughton C; Burton SL; Kilgore KM; Johnson MJ; Nabi R; Legere T; Sher ZJ; Chen X; Amara RR; Hunter E; Bosinger SE; Spearman P; Crotty S; Villinger F; Derdeyn CA; Wrammert J; Pulendran B
J Virol; 2017 Feb; 91(4):. PubMed ID: 27928002
[TBL] [Abstract][Full Text] [Related]
18. Current efforts on generation of optimal immune responses against HIV through mucosal immunisations.
Vajdy M
Drugs R D; 2006; 7(5):267-88. PubMed ID: 16922589
[TBL] [Abstract][Full Text] [Related]
19. HIV-1 vaccination administered intramuscularly can induce both systemic and mucosal T cell immunity in HIV-1-uninfected individuals.
Musey L; Ding Y; Elizaga M; Ha R; Celum C; McElrath MJ
J Immunol; 2003 Jul; 171(2):1094-101. PubMed ID: 12847284
[TBL] [Abstract][Full Text] [Related]
20. The role of gammadelta T cells in generating antiviral factors and beta-chemokines in protection against mucosal simian immunodeficiency virus infection.
Lehner T; Mitchell E; Bergmeier L; Singh M; Spallek R; Cranage M; Hall G; Dennis M; Villinger F; Wang Y
Eur J Immunol; 2000 Aug; 30(8):2245-56. PubMed ID: 10940916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
